ChromaDex Corp (NAGE) - Prakiraan pendapatan perusahaan

Logo korporat perusahaan Chromadex Corp (NAGE)

The expected execution level of Chromadex Corp (NAGE) helps identify a trend reversal in time and avoid overpaying for the asset, while 0.04 serves as the current metric mark. Patents on cellular health and strict FDA oversight provide a defensive moat for the business. Revenues are generated through B2B supplies of Niagen and retail sales. Global demand for longevity components and anti-aging cosmetics ensures stable growth.

niagenbioscience.com - Prakiraan volume dodolan NAGE (periode 20.03.2025 - 15.11.2026)

Ringkesan rincian data analitis ChromaDex Corporation (NAGE)

- rega saiki lan proyeksi nilai saham:
Ringkesan analitik perusahaan:Chromadex Corp NAGE
Produk merek Niagen

The selection of defensive assets is based on a business's ability to maintain revenue during market shocks, which for Chromadex Corp (NAGE) is ensured by the uniqueness of its patents in cellular metabolism and protection against dumping. The projected sales volume measures expected cash flow, allowing an assessment of the business's fundamental stability through the company's planned sales dynamics and preventing entry into the asset at local price peaks.

Pesaing wigati

Volume dodolan mangsa ngarep perusahaan ISRG (Intuitive Surgical)|DHR (Danaher Corp) - Pendapatan mangsa ngarep perusahaan|BD - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan STERIS Group STE|WST - Prakiraan pendapatan perusahaan|Baxter International (BAX) - Volume dodolan mangsa ngarep perusahaan|Masimo Corp (MASI) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Stevanato Group|Prakiraan pendapatan perusahaan Teleflex Incorporated|Volume dodolan sing dikarepake perusahaan Merit Medical Corp MMSI|Prakiraan pendapatan perusahaan Envista (NVST)|ICU Medical - Prakiraan pendapatan perusahaan|DENTSPLY SIRONA Inc. - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan LMAT (LeMaitre Vascular Inc)|ATRC - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan STAAR Surgical Co STAA|ZIMV (ZimVie Dental) - Volume dodolan mangsa ngarep perusahaan|angiodynamics.com (ANGO) - Prakiraan volume dodolan|CERS (Cerus Inc) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan TKNO|Prakiraan pendapatan perusahaan Monogram Technologies (MGRM)|Prakiraan volume dodolan Sharps Technology Inc (STSS)|InfuSystem - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan UTMD|KRMD: Volume dodolan mangsa ngarep perusahaan|NYXH - Prakiraan volume dodolan|MBOT: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Pro-Dex, Inc. (PDEX)|Volume dodolan mangsa ngarep perusahaan ZTEK|ELUT: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Milestone Scientific Corp (MLSS)|Dodolan mangsa ngarep perusahaan NEXGEL Inc.|Prakiraan pendapatan perusahaan Retractable Tech RVP|Harvard Bioscience - Prakiraan pendapatan perusahaan|FEMY - Prakiraan pendapatan perusahaan|meihuamed.com (MHUA) - Volume dodolan mangsa ngarep perusahaan|POAI (Predictive Oncology Corp) - Volume dodolan mangsa ngarep perusahaan|Callan JMB Inc. - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan atrioncorp.com|NURO: Pendapatan mangsa ngarep perusahaan